Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles

NCT00005781 | Completed

• 2 other identifiers: 00013800-C-0138
• Study Type: observational
• Target: 600
• Locations: 1 country
• Sites: 1

Brief Summary

This study will evaluate whether digital photography is a reliable tool for diagnosing hand rashes, psoriasis and unusual moles. The findings will help determine if this method can be used in the National Health and Nutrition Examination survey (NHANES), which monitors disease in the United States. Employees of the National Institutes of Health 19 years and older may enroll in this study. Participants will complete a brief questionnaire that includes information on skin type, history of skin conditions (moles, cancer, rashes, psoriasis), and demographic information such as name, age and sex. They will be examined by a dermatologist, who will note in writing the appearance of any hand rashes, unusual moles, or psoriasis. If any areas suspicious for skin cancer are found, the participant will receive this information in writing, along with advice about where to go for treatment. A total of six photographs will then be taken of the participant's arms, legs, hands and back. The face will not be photographed, and the participants will not be identifiable.

Conditions

Dermatitis; Nevus; Psoriasis

Keywords

Epidemiology; NHANES; Photography; Prevalence; Skin Disease; Healthy Volunteer

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

Must have employee status at the National Institutes of Health. Age greater than 18 years. Able to understand and sign consent. Patients who are wheelchair bound and are unable to have images of their back and lower extremities taken safely will be excluded from photography since this portion of the examination requires an ability to stand. However, they will still be eligible to participate in the skin cancer screening.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

• National Cancer Institute (NCI): lead

Study Sites (1)

National Cancer Institute (NCI)

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

• English DR, Menz J, Heenan PJ, Elder DE, Watt JD, Armstrong BK. The dysplastic naevus syndrome in patients with cutaneous malignant melanoma in Western Australia. Med J Aust. 1986 Sep 1;145(5):194-8. doi: 10.5694/j.1326-5377.1986.tb113809.x.

  PMID: 3747894 BACKGROUND

• Albert LS, Rhodes AR, Sober AJ. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives. J Am Acad Dermatol. 1990 Jan;22(1):69-75. doi: 10.1016/0190-9622(90)70010-f.

  PMID: 2298967 BACKGROUND

• Rigel DS. Malignant melanoma: perspectives on incidence and its effects on awareness, diagnosis, and treatment. CA Cancer J Clin. 1996 Jul-Aug;46(4):195-8. doi: 10.3322/canjclin.46.4.195. No abstract available.

  PMID: 8673692 BACKGROUND

MeSH Terms

Conditions

Dermatitis; Nevus; Psoriasis; Skin Diseases

Condition Hierarchy (Ancestors)

Skin and Connective Tissue Diseases; Nevi and Melanomas; Neoplasms by Histologic Type; Neoplasms; Skin Diseases, Papulosquamous

Study Design

• Study Type: observational
• Sponsor Type: NIH

Study Record Dates

• First Submitted: June 3, 2000
• First Posted: December 10, 2002
• Study Start: May 1, 2000
• Study Completion: September 1, 2000
• Last Updated: March 4, 2008

Record last verified: 2000-05

Locations

US (1)